Pre-Denial Medical Necessity Dossier
A physician-authored dossier for a selected planned service or prior authorization — built to improve clinical completeness and argument quality before the payer’s initial review.
An exception layer for the cases your PA team should not carry alone.
A pre-decision analysis for one selected planned service or prior-authorization request. It identifies the likely coverage pathway, maps the current record to it, anticipates the medical-necessity objections, flags documentation gaps, and gives submission recommendations — before the payer decides. It is not a replacement for your normal prior-authorization operation; its value depends on selecting cases where clinical ambiguity, not routine administration, is the bottleneck.
Why pre-decision work is worth it. Preventing an avoidable denial is usually less burdensome than appealing after the service. When the required evidence exists in the record but is not organized the way the reviewer evaluates it, the dossier does that organization while the decision is still open.
Prior-authorization timelines are tightening. The record has to be ready first.
72 hours
Under the CMS Interoperability and Prior Authorization Final Rule, impacted payers must decide expedited prior-authorization requests within 72 hours.
7 calendar days
Standard requests must be decided within seven calendar days — meaning the submission the reviewer sees first is often the only one that matters.
A specific denial reason
Impacted payers must provide a specific reason for denial — which makes a submission built around the likely decision pathway more valuable, and a generic one easier to reject precisely.
These requirements apply to defined impacted payers and exclude drugs; they are not a universal rule for every plan or service. The dossier confirms which framework governs the specific request before arguing it.
Expected decision-pathway analysis
The coverage pathway the reviewer is likely to apply, identified from client-supplied, public, or otherwise authorized policy sources.
Evidence map
The current record mapped element by element to that pathway — what is already satisfied, and by which documents.
Contradiction & gap list
Facts in the record that cut against the request, and the documentation the pathway wants that is not yet there.
Preemptive objection responses
The likely medical-necessity objections answered in advance, inside what the record actually supports.
Recommended next documentation step
The specific addition — a measurement, a dated note, a treating-clinician statement — that would most strengthen the submission.
Client-writer handoff
Structured guidance for the team that assembles and submits the request through your own workflow.
Deadline fit. Standard turnaround is 3–5 business days after complete inputs — which makes the dossier unsuitable for an imminent submission unless an expedited scope is accepted at intake. If the deadline falls before a responsible review can be completed, the honest answer is to decline.
Clinical analysis before the decision
- Pathway identification from authorized sources
- Record-to-pathway evidence mapping
- Gap, contradiction, and objection analysis
- Submission recommendations and writer handoff
The authorization itself
- Portal submission and payer follow-up
- Benefits verification and eligibility checks
- Treating-clinician orders and required documentation
- Any policy guarantee — the dossier improves the argument; the payer decides
Best fit
- The normal PA team has gathered the basics and a selected case needs better clinical alignment
- High-stakes planned services where a first-pass denial would be costly to unwind
- Complex or multi-policy requests where the governing pathway is genuinely ambiguous
- Failed-conservative-therapy disputes where the sequence exists but was never organized
Not a fit
- Routine queue processing or high-volume authorization administration
- Portal work, benefits checks, or payer follow-up
- Missing treating-clinician documentation the dossier cannot create
- A submission deadline that precedes a responsible review
Quoted after scope
Pre-denial dossiers are quoted after a de-identified scope review — record size, policy complexity, and the number of material clinical issues drive the fee. Standard physician denial review begins at $450 for comparison.
3–5 business days
After complete inputs — the current record, the planned service, and the policy sources your team is authorized to use. Expedited scope by prior agreement only.
What the review must resolve before a defensible handoff.
Decision route
Which benefit, payer policy, step sequence, or setting rule will control initial review?
Current record
Which diagnosis, severity, test, prior treatment, contraindication, and function elements already exist?
Gap classification
Which missing item can be obtained, which needs clarification, and which historical fact cannot be created?
Objection forecast
What is the most likely first denial reason?
Stop rule
Is the threshold actually supportable before the packet is strengthened?
What the client provides.
Scope and turnaround begin after the agreed inputs are complete enough for a responsible review. A larger record is not automatically a better record.
- Requested service, payer, plan, date, and urgency
- Current policy or authorized criteria source
- Treating notes, tests, prior treatment, failures, and contraindications
- Draft authorization packet assembled by the client
- Any prior denial for the same request
What the analysis is designed to prevent.
The page does not assume the adverse decision is wrong. It identifies ways a supportable case can become inaccurate, overstated, or misrouted.
- Sending a large packet without locating the criterion
- Asking for a conclusion without identifying missing support
- Assuming a guideline overrides benefit or policy terms
- Using expert review for every routine authorization
- Promising approval instead of exposing weaknesses
How this service fits among current alternatives.
| Option | Typical role | Public price visibility |
|---|---|---|
| Internal PA team | Benefits, policy, documentation, portal, follow-up | Internal cost |
| Outsourced PA vendor | High-volume administration and exception handling | Some publish low per-auth starting fees |
| Criteria/automation software | Policy lookup, document collection, rules, submission | Usually private quote |
| Treating/specialty clinician | Medical judgment and required documentation | Clinical workflow cost |
| Clinician consultant | Selected complex-case analysis | Usually private quote |
Staffingly advertises $4–$8 per authorization for its broader outsourced workflow. Infinx markets an AI and automation solution but uses enterprise sales. Neither establishes the price of a clinician-authored complex dossier.
What can—and cannot—be compared.
Public administrative PA prices can be $4–$8 per authorization at scale, while enterprise automation and clinician review are quote-based. The correct comparison is not cost per routine authorization; it is the incremental cost of expert analysis for a selected exception.
When the service is the right instrument.
Choose it when the normal PA team has already gathered the basics and a selected case needs better clinical alignment. Do not choose it for routine queue processing, portal work, missing treating-clinician documentation, or a request whose deadline falls before a responsible review can be completed.
Send one de-identified matter. Initial fit assessment.
No PHI and no commitment. The initial fit response confirms scope, whether physician review may add value, required documents, and the appropriate paid engagement.